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Plant biotechnology in South Africa: Micropropagation research endeavours,
prospects and challenges
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Private Bag X01, Scottsville 3209, South AfricaAbstract
Research in plant biotechnology is playing a crucial role in the production and conservation of plant-based resources globally. Being a country with
rich and diverse floral resources, South Africa has a genuine opportunity to develop efficient and competitive plant biotechnology sectors. South Africa
has a policy framework, in the form of a National Biotechnology Strategy that supports biotechnology research. The presence of competitive research
infrastructure coupled with the government's willingness to commit significant resources will certainly help realise this. South Africa's plant
biotechnology research has potential to make more significant contributions to the national economy. In this review, whilst highlighting the success, the
research endeavours, prospects and challenges hindering the practical application of micropropagation research outputs are discussed.
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According to the United Nations Environment Programme
(UNEP) Convention on Biological Diversity, biotechnology is
defined as a body of techniques that use biological systems, living
organisms, or derivatives thereof to make or modify products or
processes for specific use (UNEP, 1992). This definition is also
adopted by the South African Biotechnology Strategy (DST,
2001). Although biotechnology is perceived as a modern science,
the above definition shows that it is an old science which has been
used for many years. The use of fermentation agents in breweries
and bakeries, processing of dairy products, development of new
animal breeds and crop cultivars have all used living organisms to
improve ormodify a product, hence fully satisfying the definition.
The discovery of DNA and development of gene technologies
however, gave biotechnology a new dimension giving it amodern
look.
Despite its rich history of using biotechnology, South Africa
has not fully exploited the full benefits of the recent advances in
biotechnology which triggered the need for a national biotech-
nology strategy to make up for lost ground (DST, 2001). Ten
years have elapsed since the adoption of the National Biotech-
nology Strategy. This review aims to assess the research
endeavours, economic prospects and challenges of plant
biotechnology research in South Africa with special emphasis
on the use of plant tissue culture in the propagation, conservation,
commercialization as well as improvement of economically
important plant species. Although biotechnology of food crops is
briefly discussed, most emphasis is given to research on the
biotechnology of non-food plants.
1.1. Plant biotechnology research in South Africa
Biotechnology research and its application in South Africa are
not very far behind when compared to the world's developed
countries. One could even argue that the country is progressing
well given the fact that it was politically isolated from the
international community for many years which resulted in
excessive reliance on local innovations (Cloete et al., 2006). In
as much as the reliance on domestic technology contributed to the
country's economy and innovation, it appears that only few
sectors such as mining, chemical and military were given national
priority and little emphasis was given to plant biotechnology
(Ofir, 1994). This however, changed since the year 2000when the
South African government made biotechnology one of its main
research focus areas by significantly increasing its support (Cloete
et al., 2006). The adoption, by the Department of Science and
Technology of the National Biotechnology Strategy in 2001
(DST, 2001) with the fundamental mission of creating severalBiotechnology Regional Innovation Centres (BRICs) to act as
nuclei for the creation of essential biotechnology platforms was a
key step. The strategy also addresses issues such as funding,
human resource development, regulatory and legal issues as well
as trying to close the gap between research and commercialization
(Cloete et al., 2006). These BRICs recently formed the
Technology Innovation Agency (TIA) under the National System
of Innovation (NSI) (DST, 2009).
Micropropagation, conservation and commercialization-based
research on the biotechnology of plants are relatively new in
South Africa. The past couple of decades however, witnessed a
boom in research outputs on biotechnology of plants. This is
mainly due to the following important interrelated factors:
1. The need to maximise food productivity;
2. Acknowledgement of the concept of indigenous knowledge—
there is a strong relationship between the history of the people
of South Africa and the traditional use of plants. This rich
history and knowledge of plant use is serving as the foundation
for cutting edge biomedical research ranging from the
characterization and isolation of active principles to their
mass production in vitro using bioreactor systems;
3. Environmental issues— due to the impact of fossil fuel on the
environment, the use of plants as a substitute to fossil fuel is
gaining popularity. This has resulted in an increase in research
endeavours geared towards realising the potential of plants as a
source of environmentally friendly energy;
4. Availability of rich floral resources — southern Africa is
amongst the richest regions of the world in floral diversity with
about 30 000 species of higher plants (Goldblatt, 1978), many
of which are traditionally used for various purposes. South
Africa, with less than 2%of the world land surface, is endowed
with an estimated 10% of plant species (SANBI, 2011).
Biotechnology has emerged as an essential tool to realise the
full economic potential of these rich floral resources through
various laboratory-based techniques; for instance the produc-
tion of secondary metabolites in vitro for the pharmaceutical
and cosmetic industries using bioreactor systems and research
associated with it;
5. The need for conservation — the growing world population
has resulted in an increase on the demand of plants for food,
energy, cosmetic and pharmaceutical uses, which in turn
exerted huge pressure on wild populations of plants. Such
consumption-driven pressure coupled with unsustainable use
of plants has warranted the need for urgent conservation
measures. Plant tissue culture is playing a key part in this
regard; especially for plants that are difficult to propagate as
well as those that have lost their natural pollinators due to
habitat loss.
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Research activities in biotechnology can have an impact on
industries involved in the agricultural, horticultural, environmen-
tal, pharmaceutical and medical sectors. Despite its potential,
emphasis on the adoption, diffusion and regulation of plant
biotechnology remained largely in the area of agricultural
biotechnology with the other sectors still in their infancy
(Andanda, 2009). Nonetheless, compared to other African
countries, South Africa is producing high outputs in the fields
of plant tissue culture, molecular biology, genetic transformation
and conservation of endangered plant species.
The main focus area of this review is research in plant tissue
culture. However, the world class research outputs by the various
South African universities and research institutions in molecular
marker development, genetic fingerprinting, genetic manipula-
tion as well as gene expression profiling and gene discovery of
economically important plants such as potato, sugarcane,
eucalyptus, maize, soybean, wheat, amongst others are worth
mentioning.
Research in plant tissue culture and its associated applica-
tions such as genetic transformation constitute one of the major
areas of plant biotechnology research in South Africa. Its
primary objectives are to increase food productivity, conserva-
tion, promotion of sustainable use and commercialization,
production of secondary metabolites, understanding the growth
requirements of plants as well as development of molecular
markers (Bornman et al., 2004; Botha et al., 2004; Okole and
Odhav, 2004; Berjak et al., 2011). Although there is no defined
pecking order as far as the target areas of research in non-food
plant biotechnology research goes, it appears from recent
publications that in vitro conservation of endangered and
recalcitrant species (Berjak et al., 2011) as well as propagation
of medicinal and ornamental bulbs (Fennell and Van Staden,
2004) are receiving significant attention.
1.3. Conservation of plant biodiversity
South Africa is characterized by a population known for
excessive reliance on its plant resources for food, medicine,
cultural and spiritual demands. Trading plant parts in urban and
semi-urban streets is one of the peculiar features of South Africa.
Unfortunately, the harvesting and trading of plants is not fully
regulated and/or controlled hence lacking sustainability. As a
result, there is a need to introduce corrective and protective
measures. One such measure was to determine the conservation
status of individual plant species— commonly referred to as the
National Red List of South African Plants. The Red List is used as
a resource for conservation-based research as well as for
formulating laws and policies on the harvesting, marketing and
use of plants in need of protection. It is being used extensively by
scientists whose focus area is in vitro and in situ conservation.
The development of plant biotechnology in general, and
plant tissue culture techniques in particular, have changed the
face of conservation of genetic resources. The past half a
century witnessed the development of countless plant cell and
tissue culture techniques and protocols which undoubtedly hasrescued many species from extinction. South African research is
contributing its share by developing biotechnology-based
propagation and conservation methods. Such methods include
in vitro propagation of endangered and recalcitrant species, slow
growth storage, cryopreservation, in vitro production of second-
ary metabolites to reduce the pressure on wild population and re-
introduction of rare species to natural habitats. Such practises are
complimenting the traditional in situ conservation endeavours.
1.4. Commercialization
Commercialization of plants and their secondarymetabolites is
one of the major driving forces behind the advancement of plant
biotechnology research in South Africa. Obviously, the commer-
cialization of plant products should be preceded by evaluation of
species for the presence of target substances and product
development. In addition to its role in plant conservation, research
in plant biotechnology is playing an important role in adding
value to South Africa's floristic resources. Protecting wild plant
populations from over-exploitation, maintaining the gene pool
through clonal propagation of superior species and ease of
marketing (transport and handling) of plant material are some of
the benefits biotechnology research is offering to commerciali-
zation (Okole and Odhav, 2004).
1.5. Growth, physiology and molecular biology
Once a plant is identified as a target of research for conser-
vation or commercialization purposes or both, understanding its
growth requirements and genetics are of paramount importance.
As a result, research geared towards understanding the growth,
physiology and molecular biology of plants is amongst the main
target areas of research in South Africa. Tissue culture techniques
provide easy, reliable and reproducible approaches for such
research due to the possibility tomanipulate and control sources of
variation. In addition, specialised experiments such as assessing
the plants' ability for the production of secondary metabolites
in vitro can be done. Table 1 provides an example of some plants
that have been studied in SouthAfrica. Tissue culture experiments
have also been complimented by genetic fidelity studies using
molecular techniques to ensure genetic uniformity of regenerants.
1.6. Universities and research institutions
Unlike other African countries, South Africa has the features
of both the developed and developing worlds (Al-Bader et al.,
2009). Its universities and research institutions have advanced
research facilities and systems. South Africa also has univer-
sities comparable with the best in the world; the University of
Cape Town for example, was ranked 161 in the world in the
year 2010 (QS World University Ranking, 2010). Most
universities in South Africa either have dedicated research
centres for biotechnology or provide biotechnology training at
both under- and post-graduate levels.
In addition to the universities, the country has well
established research institutions such as the Agricultural
Research Council (ARC), Medical Research Council (MRC)
Table 1
Applications of in vitro biotechnology for some plant species of economic importance.
Plant species Plant family Plant uses Conservation
status a
Biotechnology
application
References
Alberta magna Rubiaceae Horticultural LC Micropropagation Ben-Jaacov et al. (1991)
Albuca bracteata b Hyacinthaceae Medicinal; horticultural XX Micropropagation Ascough and Van Staden (2010)
Albuca nelsonii Hyacinthaceae Medicinal; horticultural LC Micropropagation Ascough and Van Staden (2010)
Aloe polyphylla c Asphodelaceae Medicinal; horticultural EN Micropropagation Abrie and Van Staden (2001),
Chukwujekwu et al. (2002) and Bairu et al.
(2007)
Babiana angustifolia;
B. disticha b; B. stricta;
B. rubrocyanea;
B. patersoniae; B. villosa
Iridaceae Floriculture NT; XX; NT;
VU; LC; NT
Micropropagation McAlister et al. (1998b)
Barleria greenii Acanthaceae Medicinal CR Micropropagation Amoo et al. (2011)
Bowiea volubilis Hyacinthaceae Medicinal VU Micropropagation;
secondary metabolites
`Cook et al. (1988), Van Staden et al.
(1991), Finnie et al. (1994) and Hannweg
et al. (1996)
Brunsvigia undulata Amaryllidaceae Medicinal Rare Micropropagation Rice et al. (2010)
Centella asiatica Apiaceae Medicinal LC Secondary metabolites James et al. (2008)
Coffea arabica Rubiaceae Food n/a In vitro storage Mycock et al. (1995)
Crinum macowanii Amaryllidaceae Medicinal; ornamental D Micropropagation Slabbert et al. (1993, 1995)
Crinum moorei Amaryllidaceae Medicinal; ornamental VU Secondary metabolites Fennell et al. (2003)
Crinum variabile Amaryllidaceae Floriculture LC Micropropagation Fennell et al. (2001)
Cussonia paniculata Araliaceae Medicinal; horticultural LC Micropropagation Tetyana and Van Staden (2001)
Cyrtanthus brachyscyphus;
C. breviflorus; C. elatus;
C. falcatus; C. guthrieae;
C. mackenii
Amaryllidaceae Medicinal LC; LC; LC;
Rare; CR; NT
Micropropagation McAlister et al. (1998a)
Dierama erectum Iridaceae Medicinal; horticultural EN Micropropagation Koetle et al. (2010)
Dierama latifolium Iridaceae Horticultural/Floriculture LC Micropropagation Page and Van Staden (1985)
Dierama luteoalbidum Iridaceae Horticultural VU Micropropagation Madubanya et al. (2006)
Drimia robusta Hyacinthaceae Medicinal DDT Micropropagation Ngugi et al. (1998)
Drosera natalensis Droseraceae Medicinal LC Micropropagation Crouch and Van Staden (1988)
Eucalyptus grandis;
E. grandis×
E. urophylla; Eucalyptus
grandis×E. nitens hybrid
Myrtaceae Forestry/Timber n/a Micropropagation;
In vitro field collecton;
In vitro storage
Watt et al. (1991), Jones and Van Staden
(1994), Watt et al. (2000a, 2000b, 2003a),
Mokotedi et al. (2003), Hajari et al. (2006)
and McAlister et al. (2005)
Eucomis autumnalis Hyacinthaceae Medicinal; ornamental D Secondary metabolites Taylor and Van Staden (2001b, 2001c)
Eucomis autumnalis,
E. comosa, E. zambesiaca
Hyacinthaceae Medicinal; Horticultural D; D; LC Micropropagation Ault (1995a)
Eucomis L'Herit b Hyacinthaceae Medicinal; horticultural XX Micropropagation Taylor and Van Staden (2001a)
Eucomis poleevansii b Hyacinthaceae Medicinal; horticultural XX Micropropagation McCartan and Van Staden (1996)
Eucomis zambesiaca Hyacinthaceae Medicinal; horticultural LC Micropropagation Cheesman et al. (2010)
Eulophia cucullata;
E. petersii; E. streptopetala
Orchidaceae Medicinal LC; LC; LC Micropropagation McAlister and Van Staden (1998)
Galtonia candicans,
G. viridiflora
Hyacinthaceae Horticultural LC; LC Micropropagation Drewes and Van Staden (1993)
Gethyllis linearis Amaryllidaceae Medicinal LC Micropropagation Drewes and Van Staden (1994)
Gladiolus carneus Iridaceae Medicinal LC Micropropagation Jäger et al. (1998)
Gladiolus flanaganii Iridaceae Horticultural LC Micropropagation Dickens et al. (1986)
Gloriosa superba Colchicaceae Floriculture LC Micropropagation Finnie and Van Staden (1989)
Haemanthus deformis;
H. humilis; H. albiflos
Amaryllidaceae Medicinal NT; LC; LC Micropropagation Rabe and Van Staden (1999)
Harpagophytum procumbens Pedaliaceae Medicinal LC Micropropagation;
secondary metabolites
Shushu (2001), Jain et al. (2009) and Bairu
et al. (2011a)
Haworthia limifolia;
H. koelmeniorum
Liliaceae Medicinal VU; EN Micropropagation Mycock et al. (1997)
Helichrysum aureonitens Asteraceae Medicinal LC Secondary metabolites Ziaratnia et al. (2009)
Hoslundia opposita Lamiaceae. Medicinal LC Micropropagation Prakash and Van Staden (2007)
Huernia hystrix Asclepiadaceae Medicinal LC Micropropagation Amoo et al. (2009a, 2009b)
Hypoxis acuminata;
H. colchcifolia;
H. hemerocallidea;
H. obtusa; H. rigidula
Hypoxidaceae Medicinal; horticultural LC; LC; D;
LC; LC
Micropropagation Appleton and Van Staden (1995)
Hypoxis rooperi b Hypoxidaceae Medicinal XX Micropropagation Page and Van Staden (1986)
(continued on next page)
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Table 1 (continued)
Plant species Plant family Plant uses Conservation
status a
Biotechnology
application
References
Ischyrolepis subverticillata Restionaceae Horticultural LC Micropropagation McCartan et al. (2004)
Kniphofia leucocephala Asphodelaceae Medicinal CR Micropropagation McCartan and Van Staden (2003) and
Taylor et al. (2005)
Kniphofia pauciflora Asphodelaceae Medicinal CR Micropropagation McAlister and Van Staden (1996)
Lanchenalia arbuthnotiae;
L. bulbifera;
L. purpureo-coerulea
Hyacinthaceae Horticultural CR; LC; CR Micropropagation Ault (1995b)
Lanchenalia hybrids Hyacinthaceae Horticultural n/a Micropropagation Nel (1983), Niederwieser and Vcelar (1990),
Niederwieser and Van Staden (1990, 1992),
Niederwieser et al. (1992) and Slabbert and
Niederwieser (1999)
Lapeirousia silenoides Iridaceae Floriculture LC Micropropagation Louw (1989)
Leucadendron discolor Proteaceae Floriculture VU Micropropagation Pérez-Francés et al. (2001b)
Leucospermum ‘Sunrise’ Proteaceae Floriculture n/a Micropropagation Pérez-Francés et al. (2001a)
Manihot esculenta Euphorbiaceae Food n/a In vitro storage;
Somatic embryogenesis
Mycock et al. (1995) and Rossin and Rey
(2011)
Maytenus senegalensis b Celastraceae Medicinal XX Micropropagation;
secondary metabolites
Matu et al. (2006) and Jain et al. (2008)
Merwillia plumbea
(formerly-Scilla natalensis)
Hyacinthaceae Medicinal LC Micropropagation McCartan and Van Staden (1998)
Mondia whitei Periplocaceae Medicinal EN Micropropagation McCartan and Crouch (1998)
Musa spp. AAA Musaceae Food n/a Micropropagation Bairu et al. (2006, 2008)
Ornithogalum
longibracteatum
Hyacinthaceae Floriculture LC Micropropagation Malabadi and Van Staden (2004)
Ornithogalum maculatum Hyacinthaceae Floriculture LC Micropropagation Van Rensburg et al. (1989)
Ornithogalum thyrsoides Hyacinthaceae Floriculture LC Micropropagation Hussey (1976)
Ornithogalum thyrsoides;
O. dubium
Hyacinthaceae Floriculture LC Transformation;
transgenic technology
De Villiers et al. (2000)
Oxalis reclinata Oxalidaceae Food; pharmaceutical LC Secondary metabolites Crouch et al. (1993) and Makunga et al.
(1997)
Oxalis reclinata; O. Variifolia;
O. Helicoides; O. gracilis
Oxalidaceae Floriculture LC; CR PE;
LC; LC
Micropropagation Crouch and Van Staden (1994)
Pelargonium sidoides Geraniaceae Medicinal D Secondary metabolites Colling et al. (2010a)
Pennisetum glaucum Poaceae Food n/a Micropropagation;
transformation
O'Kennedy et al. (2004a, 2004b)
Picea abies Pinaceae Foresty/timber n/a Micropropagation Bornman et al. (2003)
Pinus elliotlii; P. caribaea Pinaceae Timber/Forestry n/a Micropropagation Meyer (1998)
Pinus patula Pinaceae Timber n/a Micropropagation;
artificial seed
encapsulation;
transgenic technology
Jones and Van Staden (1993, 1995), Sparg
et al. (2002), Malabadi and Van Staden
(2003, 2005a, 2005b) and Nigro et al.
(2004b, 2008)
Podocarpus henkelii;
P. elongatus Podocarpaceae Medicinal LC; LC Micropropagation Kowalski and Van Staden (2001)
Protea cynaroides Proteaceae Floriculture LC Micropropagation Wu and du Toit (2004) and Wu et al.
(2007)
Protea neriifolia Proteaceae Floriculture LC Micropropagation Van Staden et al. (1981)
Protea repens Proteaceae Floriculture LC Micropropagation Rugge (1995)
Rhodohypoxis baurii Hypoxidaceae Horticultural LC Micropropagation Upfold et al. (1992)
Romulea minutiflora;
Sisyrinchium laxum b;
Tritonia gladiolaris
Iridaceae Floriculture LC; XX; LC Micropropagation Ascough et al. (2011)
Saccharum sp. Poaceae Food n/a Micropropagation;
transgenic technology;
in vitro storage
Bailey and Bechet (1989), Snyman et al.
(1996, 2000, 2001, 2006, 2007, 2008b),
Meyer et al. (2009), Watt et al. (2009) and
Ramgareeb et al. (2010)
Salvia africana-lutea Lamiaceae Medicinal LC Micropropagation Makunga and Van Staden (2008)
Salvia chamelaeagnea Lamiaceae Medicinal LC Micropropagation; secondary
metabolites
Huang and Van Staden (2002)
Salvia stenophylla Lamiaceae Medicinal;
Pharmaceutical
XX Micropropagation;
secondary metabolites
Musarurwa et al. (2010)
Sandersonia aurantiaca Colchicaceae Floriculture D Micropropagation Finnie and Van Staden (1989)
Schizobasis intricata b Hyacinthaceae Medicinal XX Micropropagation Drewes et al. (1993)
Scilla krausii;
S. dracomontana
Hyacinthaceae Medicinal XX Micropropagation McCartan and Van Staden (2002)
1000 M. Moyo et al. / South African Journal of Botany 77 (2011) 996–1011
Table 1 (continued)
Plant species Plant family Plant uses Conservation
status a
Biotechnology
application
References
Scilla nervosa Hyacinthaceae Medicinal XX Micropropagation Crouch et al. (1999)
Sclerocarya birrea subsp.
caffra
Anarcadiaceae Medicinal;
pharmaceutical; Food
LC Transformation;
micropropagation
Mollel and Goyvaerts (2004) and Moyo et
al. (2009, 2011)
Searsia dentata Anarcadiaceae Medicinal LC Micropropagation Prakash and Van Staden (2008)
Sutherlandia frutescens Fabacaeae Medicinal LC Micropropagation;
secondary metabolites
Shaik et al. (2010, 2011) and Colling et al.
(2010b)
Thapsia garganica b Apiaceae Medicinal XX Micropropagation Makunga et al. (2003, 2005, 2006)
Thuranthos basuticum b Hyacinthaceae Medicinal XX Micropropagation Jones et al. (1992)
Tillandsia funckiana;
T. Ionantha c;
T. Scheideana b
Bromeliaceae Horticultural XX; VU; XX Micropropagation Chukwujekwu and Van Staden (2003)
Triticum aestivum Poaceae Food n/a In vitro androgenesis Ascough et al. (2006)
Tulbaghia simmleri Alliaceae Medicinal LC Micripropagation Zschocke and Van Staden (2000)
Tulbaghia violacea Alliaceae Medicinal LC Secondary metabolites Ncube et al. (2011)
Veltheimia bracteata Hyacinthaceae Medicinal LC Micropropagation Taylor and Van Staden (1997)
Veltheimia bracteata,
V. capensis
Hyacinthaceae Horticultural LC; LC Micropropagation Ault (1996)
Watsonia gladioloides;
W. lepida; W. laccata;
W. vanderspuyiae
Iridaceae Floriculture LC; LC; LC;
LC
Micropropagation Ascough et al. (2007)
Zea mays L. Poaceae Food n/a In vitro androgenesis;
transformation
Jäger et al. (2010) and O'kennedy et al.
(2001)
The notation n/a stands for not applicable.
a Conservation status of species is based on Red list of South African plants (2009) categories as follows: critically endangered, possibly extinct (CR PE); critically
endangered (CR); endangered (EN); vulnerable (VU); near threatened (NT); declining (D); least concern (LC); data deficient-taxonomically problematic (DDT).
b Plant species denoted by XX were neither on the Red list of South African plants (2009) nor on the IUCN Red List of Threatened Plants (1997).
c Conservation status of species based on IUCN Red List of Threatened Plants (1997).
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These universities and research institutions play a pivotal role in
the biotechnological development of the country (Cloete et al.,
2006). The presence of a dedicated research institute for
agricultural crops, the ARC, seemingly helped universities and
other research institutions to focus more on non-food plant
biotechnology research. In addition, there are also numerous
private commercial companies engaged in plant biotechnology
research and production. Some examples of private commercial
companies include, the Institute for Commercial Forestry
Research (ICFR), the South African Sugar Research Institute
(SASRI), Du Roi Laboratories, Panat, Hadeco and African
Biotechnologies Limited. An overview of research endeavours,
economic prospects and challenges of the South African plant
tissue culture-based research and the utilisation of research outputs
are discussed in the following sections.
2. Research endeavours and prospects
South Africa is endowed with an enormous and unique
plant biodiversity, which includes high value ornamental,
medicinal, aromatic, herbal, and wild food plants. The
biodiversity in South Africa accounts for 10% of the global
plant species, and is characterized by high levels of endemism
(Goldblatt, 1978; Berjak et al., 2011; SANBI, 2011). These
plants are utilised by communities contributing significantly to
the local economies, for example, about 80% of the population
in South Africa rely on medicinal plant products. The high and
increasing demand of plants for medicinal purposes hasresulted in the dwindling and sometimes extinction of some
species at an unprecedented rate due to over-harvesting. The
Red Data List (2009) classified 32 plant taxa as being extinct
with a further 1153 species teetering on the “critically
endangered” to “endangered” categories, whilst 1227 and 164
species are classified as “rare” and “critically rare”, respectively
(Berjak et al., 2011). This worrying trend in the status of
biodiversity in South Africa has, in recent times, led to more
concerted research efforts in plant conservation. However, until
recently, ex situ conservation of wild, rare and endangered species
had been negated in favour of crop species (Engelmann, 2011).
Amongst other strategies such as in situ conservation, the role of
biotechnological applications in plant conservation, specifically
in vitro or tissue culture techniques, have continued to receive
increased attention. Engelmann (2011) argues that, though ex situ
techniques can be used to complement in situmethods, they may
represent the only option for the conservation of highly
endangered and rare species. This calls for an urgent need to
develop optimal techniques for the medium to long-term storage
and rapid multiplication of both crop and wild species of
economic importance. However, despite the availability of plant
biotechnology facilities and expertise in South Africa, the
technology remains largely under-utilised in the conservation of
indigenous plant genetic resources (Berjak et al., 2011). The use
of in vitro technology offers practical applications for plant
genetic conservation of rare and endangered species, recalcitrant
seed and vegetatively propagated species, and biotechnology
products such as elite genotypes and genetically engineered crops
(Engelmann, 2011).
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It is estimated that more than 80% of the population in
developing countries is primarily dependent on herbal medi-
cines for basic healthcare needs. In addition, one-fourth of all
prescribed pharmaceuticals contain compounds that are directly
or indirectly derived from plants (Oksman-Caldentey and Inze',
2004). Furthermore, 11% of the 252 pharmaceutical drugs
considered as basic and essential by the World Health
Organisation are synthesised from plants (Rates, 2001). The
high demand on medicinal plants has led to loss of genetic
diversity, local extinctions and habitat degradation in some
places (Canter et al., 2005). Micropropagation protocols have
been developed over the past few decades for numerous
medicinal plant species, some of which are near extinct, rare or
critically endangered (Table 1). In particular, research efforts by
Universities, Research institutions such as CSIR and ARC, and
private laboratories, have made a major contribution in this
regard. As stated by Ascough and Van Staden (2010), the
Research Centre for Plant Growth and Development (RCPGD),
University of KwaZulu-Natal has successfully conducted
micropropagation research of indigenous plant species that are
used for medicinal purposes. To date this research group has
developed tissue culture protocols for over 150 plant species as
part of its postgraduate training programme. The Forestry and
Agricultural Biotechnology Institute (FABI) at the University of
Pretoria is also contributing significantly in research and
postgraduate training in biotechnology and genetics of forest
and agricultural crops. Similar efforts on germplasm conserva-
tion of both medicinal and other species of economic
importance have focussed on cryopreservation strategies using
in vitro, cold and ultra-cold technologies (reviewed by Berjak
et al., 2011). Several in vitro propagation protocols were
developed for critically endangered and possibly extinct species
(Crouch and Van Staden, 1994), critically endangered species
(Ault, 1995b; McAlister et al., 1998a; McCartan and Van
Staden, 2003; Taylor et al., 2005; Amoo et al., 2011),
endangered species (Mycock et al., 1997; McCartan and
Crouch, 1998; Chukwujekwu et al., 2002; Bairu et al., 2007;
Koetle et al., 2010), vulnerable species (Cook et al., 1988; Van
Staden et al., 1991; Finnie et al., 1994; Hannweg et al., 1996;
Mycock et al., 1997; Pérez-Francés et al., 2001a; Madubanya et
al., 2006), near threatened species (McAlister and Van Staden,
1998; Rabe and Van Staden, 1999), and declining species
(Finnie and Van Staden, 1989; Slabbert et al., 1993,1995; Ault,
1995a; Appleton and Van Staden, 1995; Taylor and Van
Staden, 2001b, 2001c). However, a comprehensive approach to
the conservation of plant germplasm using in vitro technology
should include the optimization of both micropropagation and
cryogenic protocols. Such a dual-pronged approach will enable
both the storage and propagation of the species.
2.2. Production of secondary metabolites
Apart from primary metabolites, higher plants also synthesise
a range of secondarymetabolites, which are lowmolecular weight
compounds. Plant secondary metabolites are compounds thathave no functional role in the maintenance of fundamental
physiological and biochemical processes in the plants that
synthesise them, but protect the plants in their interaction with
the environment (Oksman-Caldentey and Inze', 2004). Plant
tissue culture provides valuable tools for harnessing secondary
metabolites because cells are biosynthetically totipotent and, thus
have the genetic capacity to synthesise the same range of
chemicals inherent in the parent plant. In addition, novel
compounds can also be synthesised through biotransformation
(Shanks and Morgan, 1999). Hence, Ramachandra Rao and
Ravishankar (2002) highlighted that plant biotechnology offers
the opportunity to exploit in vitro cell, tissue and organ culture and
to genetically manipulate them to produce the desired secondary
metabolites. The option of using plant cell cultures continues to
gain prominence because chemical synthesis of plant-derived
compounds is often not economically feasible due to the high
complexity of their structures and specific stereochemical
requirements (Oksman-Caldentey and Inze', 2004). Secondly,
many of the plant species endowed with these compounds are
difficult to cultivate or have become endangered because of non-
sustainable harvesting practises (Oksman-Caldentey and Inze',
2004).
In certain instances, secondary metabolites are only produced
in organ cultures such as hairy roots. Thus, the ability of
Agrobacterium rhizogenes to induce hairy roots in a range of
plants has been exploited as a source of root-derived pharmaceu-
tical compounds. Hairy roots are characterized by high growth
rates, high proliferation in plant growth regulator-free medium,
high branching, genetic and biochemical stability, and production
of secondary metabolites over a long time period (Flores et al.,
1999; Shanks and Morgan, 1999; Guillon et al., 2006).
Transformation of plant roots with A. rhizogenes today is a
commonly used technique to amplify in vitro production of
secondary metabolites (Matkowski, 2008). Colling et al. (2010a)
for example, transformed Pelargonium sidoides with rol genes
and established highly regenerative transgenic root clones, which
produced commercially important coumarins, flavonoids and
phenolic acids at significantly high concentrations. The authors
concluded that the system has potential as an in vitro conservation
system for this medicinally important South African plant.
Secondary metabolites can also accumulate when in vitro
cultures are subjected to chemical stimuli and/or environmental
stress conditions (Nigro et al., 2004a; Oksman-Caldentey and
Inze', 2004). Triterpenoid saponins were quantified in undiffer-
entiated cultures (callus, cell suspensions) and leaves of in vitro
Centella asiatica cultures (James et al., 2008). Biosynthesis of
L-canavanine, a secondary metabolite in Sutherlandia frutescens,
was produced in significant concentrations by manipulating
environmental factors such as water stress, nitrogen levels and
salinity (Colling et al., 2010b; Shaik et al., 2011). The aromatic
medicinal plant, Salvia stenophylla, was induced to produce
volatile compounds, including α-bisabolol, an important com-
pound in the cosmetic industry, by manipulating the in vitro
microenvironment (Musarurwa et al., 2010). These recent
findings in in vitro secondary metabolite production support
previous work done on other South African plant species, such as
Oxalis reclinata (Crouch et al., 1993; Makunga et al., 1997),
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et al., 2003),Eucomis autumnalis (Taylor andVan Staden, 2001b,
2001c), and Salvia chamelaegnea (Huang andVan Staden, 2002).
In some cases in vitro produced secondary metabolites have
been evaluated for pharmacological activities. Taylor and Van
Staden (2001b, 2001c) reported on the high anti-inflammatory
activities of Eucomis autumnalis in vitro extracts against
cyclooxygenase (COX)-1 and -2 enzymes. Similarly, hairy
root extracts of Maytenus senegalensis induced through
Agrobacterium-mediated transformation exhibited slightly
higher antibacterial activities compared to untransformed root
extracts (Jain et al., 2008). Recently, Ncube et al. (2011)
demonstrated that the antibacterial activity of in vitro and wild
Tulbaghia violacea extracts were equally effective.
Over the past two decades the concept of plant-based
production of high-value pharmaceutical proteins such as
vaccines and antibodies has received growing research interest,
and offers critical advantages over traditional bacterial or
mammalian cell-based systems (Rybicki, 2010; Xu et al.,
2011). The production of recombinant proteins using either
whole-plants (Chikwamba et al., 2002) or in vitro plant cell
cultures commonly known as molecular farming is emerging as a
promising prospect for the pharmaceutical industry. The major
advantages of plant cell cultures in this regard pertains to the
consistency of protein products, rapid proliferation of cell
cultures, low risk of pathogen contamination associated with
mammalian and bacterial systems, and fewer regulatory,
environmental and safety compliance mandates (Shih and
Doran, 2009). However, research efforts are still required to
solve technological bottlenecks associated with scaling-up of
flask-based plant cell cultures to industrial bioreactors (Xu et al.,
2011) and increasing the yield of proteins (Shih andDoran, 2009).
The emergent research area of molecular farming in the
production of valuable pharmaceuticals has been recently
reviewed by Shih and Doran (2009) Rybicki (2010) and Xu
et al. (2011).
2.3. Floriculture and ornamental plants
Mankind has always been fascinated by flowers. The
contagious effects of flowers emanating from their beauty and
aesthetic value has, over the centuries, led to domestication,
cultivation, selection and breeding of desired traits, in the process
metamorphosising floriculture into a global multi-billion dollar
industry. According to Bester et al. (2009), the global value of
floriculture products is estimated to be in excess of US$9 billion
per annum. The southern Africa region has made a significant
contribution to this worldwide flower market by providing floral
variety that is inherent in its unique genetic diversity. In particular,
South Africa's Cape Floral Kingdom, which displays a
spectacular floral show in spring, has over 8500 indigenous
flowering species (Van Vuuren, 1995; Bester et al., 2009) out of a
total of more than 30,000 in the southern Africa region (Fennell
and Van Staden, 2004). This tremendous floral wealth has
continued to attract attention of botanists, horticulturists and plant
enthusiasts, resulting in many species with ornamental potential
being taken from South Africa. These plants have been bred intonumerous cultivars and are now widely cultivated in many places
such as Europe, USA, China, Australia and New Zealand (Van
Vuuren, 1995). For example, nearly all of the 280 Pelagornium
species, which are amongst the most economically important
bedding and pot plants in North America and Europe have their
origins in South Africa (reviewed byMithila et al., 2001). Several
of these South African plants are amongst the top 10 flower
species on the European floriculture market (Bester et al., 2009).
Amongst the most important economic species are those
belonging to the families Amryllidaceae (e.g. Crinum spp.),
Hyacianthaceae (e.g. Eucomis spp., Lanchenalia spp., Ornitho-
galum spp.), Iridaceae (e.g. Watsonia spp., Babiana spp.,
Gladiolus spp., Iris spp.,) and Proteaceae (e.g. Protea spp.,
Leucospermum spp., Leucadendron spp.).
Plant tissue culture and its related biotechnology techniques
have made significant contributions in the growth of the
floriculture industry through mass micropropagation of healthy
plantlets and the facilitation of molecular breeding applications.
In vitro propagation protocols have been developed for several
specieswith ornamental and/or floriculture potential, for example,
Eucomis spp. (Ault, 1995a; Cheesman et al., 2010), Babiana spp.
(McAlister et al., 1998b), Lanchenalia spp. (Nel, 1983;
Niederwieser and Vcelar, 1990; Niederwieser and Van Staden,
1990, 1992; Niederwieser et al., 1992; Ault, 1995b; Slabbert and
Niederwieser, 1999), Ornithogalum spp. (Hussey, 1976; Van
Rensburg et al., 1989; De Villiers et al., 2000; Malabadi and Van
Staden, 2004),Protea spp. (Van Staden et al., 1981; Rugge, 1995;
Pérez-Francés et al., 2001a, 2001b), Watsonia spp. (Ascough
et al., 2007). The use of tissue culture-based technologies has
facilitated the rapid multiplication of valuable clones, such as
Clivia spp., whichwould otherwisemature from seed to flowering
in 3–7 years (Kim and De Hertogh, 1997; Ran and Simpson,
2005). The use of micropropagation and related biotechnologies
was reviewed for ornamental flowering bulbs (Kim and De
Hertogh, 1997; Fennell and Van Staden, 2004), Hyacinthaceae
(McCartan and Van Staden, 1999), ornamental geophytes
(Ascough et al., 2008), Iridaceae (Ascough et al., 2009), and
the genera Lanchenalia and Ornithogalum (Niederwieser, 2004).
2.4. Forest biotechnology
Eucalyptus and conifer species, namely, Pinus and Picea and
their hybrids, are important commercial forestry trees, which are
used for a wide variety of products in the timber, pulp and
pharmaceutical industries. Conifers, which are characterized by
long regeneration cycles and short juvenility periods, are open-
pollinated, heterozygous and exhibit severe inbreeding depres-
sion (Bornman, 2002). This makes conventional breeding long-
term and difficult as plant breeders strive to meet the growing
demand for commercial forestry with superior growth potential.
In vitro biotechnology systems offer the ability to produce new
elite genotypes through the processes of mutagenesis, soma-
clonal variation and genetic engineering as well as the mass
propagation of clones (Hajari et al., 2006). In vitro propagation
also fixes the genotype of the donor material in terms of the
desired traits, thereby offering the most reliable means of
utilising genetic gain (Bornman, 2002). The most common
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species is based on shoot proliferation on semi-solid medium
systems (McAlister et al., 2005; see reviews by Le Roux and
Van Staden, 1991 and Watt et al., 2003b). However, despite the
success of semi-solid systems in terms of multiplication yield,
the demand for improved productivity within the shortest
possible time remains a major requirement. McAlister et al.
(2005) reported a four-to-six fold increase in shoot multiplica-
tion of Eucalyptus clones using the temporary immersion
bioreactor (RITA®) compared to the conventional semi-solid
system. The plantlets produced in the RITA® system were also
of comparatively better quality, which exhibited superior
acclimatisation competence (McAlister et al., 2005).
Despite some major achievements in Eucalyptus and conifer
micropropagation (Watt et al., 1991, 2000a, 2000b, 2003b;
Jones and Van Staden, 1993, 1994; Meyer, 1998; Sparg et al.,
2002; Bornman, 2002; Mokotedi et al., 2003; Malabadi and
Van Staden, 2003, 2005a; McAlister et al., 2005; Hajari et al.,
2006), there has been limited success using direct and indirect
organogenesis from mature plants due to their recalcitrant
nature (Bornman, 2002). In recent times, the focus on forestry
biotechnology research has attempted to harness the potential
offered by somatic embryogenesis (Malabadi and Van Staden,
2005a) and synthetic seed technology (Malabadi and Van
Staden, 2005b; and reviewed by Bornman, 2002). Both
technologies offer exciting prospects for propagation of elite
genotypes and genetically engineered plants, and germplasm
conservation through cryogenic storage, both short to medium
term and long-term (Rai et al., 2009). However, low conversion
of encapsulated propagules into plants remains one of the major
obstacles in the commercial application of this technology
(Bornman, 2002; Rai et al., 2009), hence the need for more
research efforts in this area.
2.5. Food plants
The application of in vitro biotechnology in food plants has
mainly been geared towards increasing productivity by facilitat-
ing crop breeding endeavours, to meet the food requirements of
the ever-growing human population. Classical micropropagation
still remains an important technique for certain food plants such as
Musa and Saccharum spp. According to Bairu et al. (2008),
bananas, which are an important source of carbohydrates in the
tropical and subtropical regions, are one of themost studied plants
in the field of tissue culture-based technologies. In vitro culture
systems have been critical for the rapid mass propagation of high
quality banana propagules. South Africa has commercial
laboratories such as Du Roi Laboratories and African Bio-
technologies Limited specialising in mass clonal propagation of
selected banana cultivars.
In South Africa, another intensively studied food plant using
in vitro technology is the genus Saccharum (e.g. Bailey and
Bechet, 1989; Meyer et al., 2009; Snyman et al., 2007, 2008b;
Ramgareeb et al., 2010). In vitro culture techniques using
organogenic and somatic embryogenesis have been widely
exploited for the mass propagation of elite genotypes and for
facilitating genetic engineering processes (reviewed by Snymanet al., 2008a, 2011a, 2011b). High frequency plant regeneration
has become a prerequisite for most transformation and transgenic
applications. In cereals and other crops, the in vitro culture step
exhibits strong genotypic dependence (O'Kennedy et al., 2004a,
2004b), hence the requirement to optimise specific protocols.
Plant regeneration protocols for facilitating plant breeding and
transgenic technology have been reported for Pennisetum
glaucum (O'Kennedy et al., 2004b), Triticum aestivum (Ascough
et al., 2006), Saccharum spp. (Snyman et al., 1996, 2000, 2001,
2006; Ferreira et al., 2008) and Zeamays (O'Kennedy et al., 2001;
Jäger et al., 2010).
Integrating biotechnology procedures, such as in vitro
androgenesis into current breeding programmes will shorten
cultivar development time and also create genetically homozy-
gous inbred lines (Ascough et al., 2006). Androgenesis involves
the development of a haploid sporophyte from gametophytic
pollen. In vitro androgenesis has become an indispensable
technique for producing both haploid and double haploid plants
in a quick, efficient and dependable way. The technology, which
has mainly been exploited in cereal and other conventional food
crops, has enormous potential in tree species (Srivastava and
Chaturvedi, 2008), such as Sclerocarya birrea, to circumvent
outbreeding, heterozygosity and their long regeneration cycles,
thereby producing homozygous pure lines. However, success in
the application of genetic engineering techniques in plant
breeding also relies on the availability of a diverse genetic pool.
In recent times, germplasm conservation research of food crops
has been focussed on ex situ cryogenic technology (reviewed by
Berjak et al., 2011) to complement in situ methods. Several
cryogenic protocols are available for food crops, for example,
Coffea arabica (Mycock et al., 1995), Manihot esculanta
(Mycock et al., 1995), and Saccharum spp. (Watt et al., 2009).
The biotechnological research endeavours discussed above
are only examples and do not represent the national output. The
prospects for economic growth are clear and can be realised
through investment in research and development. In addition to
the strategic plan and policy interventions, the government's
positive outlook and support to the plant biotechnology
initiative is demonstrated by the funding provided to the
various research institutions. However, the realisation of the full
economic prospects of the plant biotechnology initiative in
South Africa is hindered by the challenges outlined in the
following sections.
3. Challenges
One of the core objectives of the planning and adoption of the
National Biotechnology Strategy in South Africa was to convert
the values of the high quality research output of universities and
research institutions to national economic development. This
however, has not been achieved as required due to a multitude of
factors. Cloete et al. (2006) mentioned the lack of entrepreneurial
culture amongst SouthAfrican researchers associatedmainlywith
the cost of registering foreign patents. In addition, challenges
related to technological factors, socioeconomic factors, public
perception of biotechnology, policy issues as well as aspects
related to research priorities and dissemination of research outputs
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biotechnology research in South Africa.
3.1. Technological factors
Despite major advances in the development of plant tissue
culture technology, a number of technical bottlenecks including
physiological and developmental problems are still experienced
today. One of the main technical challenges in clonal
micropropagation is somaclonal variation (reviewed by Bairu
et al., 2011b). According to Bairu et al. (2011b), somaclonal
variation is one of the most researched and reviewed topics in
plant tissue culture, thus indicating the severity of the problem
in plant biotechnology applications. Another technical factor
that has attracted research attention in many laboratories is
hyperhydricity. Recently, Bairu et al. (2007) suggested the use
of meta-topolins as a possible remedy against the negative
effects of hyperhydricity. Alternatively, Snyman et al. (2011a,
2011b) alleviated hyperhydricity in sugarcane plantlets by using
the RITA® immersion system and manipulating various culture
conditions such as nutrients, sucrose levels and immersion
regimes. In addition, in vitro shoot-tip necrosis has also plagued
plant tissue culture applications, in particular micropropagation
of woody species (reviewed by Bairu et al., 2009).
The ultimate goal in the biotechnology of medicinal plants
for secondary metabolites is the scaling-up from research
laboratories to large-scale industrial production (Guillon et al.,
2006; Matkowski, 2008). However, despite cell cultures having
been established for many plants, the potential offered by the
‘plant cell factory’ has had only limited commercial success due
to several technical bottlenecks such as low productivity and
bioprocess engineering challenges (Shanks and Morgan, 1999;
Oksman-Caldentey and Inze', 2004). Currently, bioreactor
technology remains relatively expensive thereby affecting
scaling-up potential for industrial production of secondary
metabolites. One option to circumvent the high capital costs of
bioprocess technology is to increase productivity several-fold,
hence the need for more research and development efforts in
this regard. The interest of industry in the ‘plant cell factory’
concept will probably continue to energise research efforts so as
to adapt the model to new scales and diverse objectives (Guillon
et al., 2006). Research into the fundamentals of biosynthetic
pathways and the regulatory mechanisms controlling plant
secondary metabolism will expand our understanding of their
synthesis and facilitate the precise manipulation of biochemical
processes for increased productivity.
3.2. Socioeconomic factors
Inadequate infrastructures for scaling-up bioreactor technol-
ogy, lack and/or loss of skilled human resources, as well as the
cost of technology development and transfer (Fennell and Van
Staden, 2004) are amongst the major constraints still facing the
applications of plant biotechnology in South Africa. It was
acknowledged in the National Biotechnology Strategy for South
Africa (DST, 2001) that a lack of adequate expertise and skills is
a major constraint in the application of biotechnology in SouthAfrica. This situation is exacerbated by limited employment
opportunities for graduates in the academic and industrial sectors
resulting in a general lack of interest in this field, coupled with
lack of adequate or sustainable project running costs. Although
interventions such as an active international recruitment pro-
gramme and establishment of remuneration packages competitive
with those on international markets have been suggested (DST,
2001) as measures for the development and retention of human
resources for biotechnology, more is required to implement this
strategy and reverse the current trend from ‘brain drain’ to ‘brain
gain’. The creation of more biotechnology regional innovation
centres (now absorbed into TIA), an intervention recommended
in the National Biotechnology Strategy, could promote the
development of skilled human resources for biotechnological
advances and application.
Plant biotechnology companies are characterized by the need
for multiple rounds of funding until they become self-sustainable.
A key limiting factor for the development and expansion of the
plant biotechnology sector in South Africa is lack of sufficient
start-up funding or investment capital. This obstacle is described
as ‘the single biggest obstacle’ to realising the potential of plant
biotechnology (Sherwin, 2006). Biotechnology companies in
South Africa receive less funding compared to those in America
and Europe. Thismakes the initial establishment aswell asmarket
competition and sustainability in technology advancement
difficult. This is possibly why there are not many plant
biotechnology business sectors or enterprises in South Africa
translating the research endeavours to economic value. The DST,
during the past nine years or so, has put a commendable initiative
in place to bridge the gap between research and commercializa-
tion by supporting a number of research projects in plant
biotechnology through PlantBio (now absorbed into TIA). One
notable example is the establishment of a plant tissue culture
company in George supported by PlantBio. Unfortunately the
success rate of such ventures cannot be accurately measured due
to lack of information. In the presence of sound research
endeavours and rich plant resources in South Africa; a more
coordinated funding system would undoubtedly help overcome
the economic challenges. A review of the biotechnology funding
environment in South Africa has recently been provided (Pouris,
2008).
3.3. Dissemination of research outputs
A search of the literature reveals that many micropropagation
protocols have been developed for South African medicinal
and/or ornamental plants (Table 1). Most of these protocols
however, end up in academic journals and the outputs often do
not get to the end-users who have little or no access to these
published articles. The increased pressure on academics to
‘publish or perish’ coupled with the performance appraisal
mechanism (Cloete et al., 2006) often based on the number of
published research articles has also resulted in research lacking
market or commercial value. The desire to publish research
articles in high-impact scientific journals has therefore become
the major driving force in the scientific communities with less
consideration for their commercialization or market value.
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Brink et al. (1998) recommended that a national biotechnology
policy strategy be developed in each country for biotechnology
development in Africa. A national biotechnology strategy was
subsequently formulated in 2001 for South Africa. This strategy
was developed to fill some identified gaps in the development and
application of biotechnology in South Africa. Whilst some of the
proposed interventions have been attended to, there is a constant
need to review existing policy and legal framework in order not to
hamper recent developments in the field of biotechnology being a
rapidly evolving field (DST, 2001). A major policy boost is the
recent South Africa Act (Intellectual Property Rights from
Publicly Financed Research and Development Act No. 51 of
2008) which provides for the establishment of National
Intellectual Property Management Office and the Intellectual
Property Fund as well as the creation of Technology Transfer
offices in higher education institutions. This Act, which ensures
the provision of financial incentives to researchers in SouthAfrica
and required support for registering patents, could greatly
facilitate the commercialization of plant biotechnology research
outputs. More awareness programmes sensitising University
researchers of the benefits need to be planned and implemented.
3.5. Research priorities
It is very crucial that plant biotechnology research focus on
national needs if the technology is to be applied in a beneficial
manner. A good collaboration network or linkage between end-
users, industries and researchers could be helpful to scientists in
applying biotechnological methods towards solving practical
problems. Bornman et al. (2004) recommended that research
efforts should not only be concentrated on large commodity
crops to the point that less commercial indigenous species are
neglected. Such indigenous species could be developed as new
crops with a large commercial potential. In funding biotech-
nology research projects, close attention should be given to the
relevance of the proposed project to the national/regional needs.
There may also be a need for a paradigm shift when it comes to
rewarding research productivity. More incentives may have to
be given to research addressing immediate national needs. The
development of low cost biotechnology options (International
Atomic Energy Agency, 2004) and synthetic seeds would
facilitate application of such technology by the end users.
3.6. Public perception and/or understanding of biotechnology
Despite the benefits and the incorporation of bio-safety
regulations in the legal framework for biotechnology applica-
tions, the general population lacks the necessary scientific
understanding of the basic principles involved in the develop-
ment of some biotechnology products, e.g. genetically modified
foods (GMO). Many plant gatherers and practitioners of
traditional medicine are of the opinion that cultivated plant
species (including micropropagated plants) do not contain
essentially the same bioactive constituents (qualitatively and/or
quantitatively) or healing power as their wild counterparts. Suchkind of understanding results in an apathetic attitude towards
biotechnology products. In order to address this challenge, the
National Biotechnology Strategy for South Africa (2001)
recommended two interventions, namely: (i) articulation of a
single biotechnology vision, and (ii) promotion of public
education about technology. The latter would include public
campaigns and workshops (involving the media houses) as well
as the incorporation of biotechnology-related matters in the
school (primary to tertiary) curriculum. The establishment of
Public Understanding of Biotechnology Programme under the
Department of Science and Technology should be able to bridge
the gap between the public and the benefits and application of
biotechnology in South Africa.
4. Conclusions
Despite the many achievements and potentials of plant
biotechnology in propelling economic development and allevi-
ating poverty, amongst others, its industrial and commercial
applications are still limited by a number of factors. In addition to
the obvious economic factors, better understanding by govern-
ment of research and its outcomes remains one of the key factors
influencing the process. Thus, to successfully overcome these
challenges, close cooperation between the key players involved in
the research and development, and industrial application of
biotechnology, including scientists, industry, policy makers, and
the general public would be required.
The role of biotechnology in harnessing the economic potential
of South African plants in the areas of floriculture, food, forestry,
medicinal and pharmaceutical secondary metabolites remains
indispensable to humanity. Over the past few decades, amyriad of
plant biotechnology innovations have been achieved in South
Africa laying a firm foundation for future research and
development endeavours. Other growing research areas involving
plant tissue culture techniques in South Africa include synthetic
seed technology,molecular farming (biopharming) and bioreactor
technology for secondary metabolite production. These rapidly
growing fields of plant biotechnology research offer immense
possibilities in long and short-term conservation, micropropaga-
tion and production of pharmaceutical proteins.
Further advancements in the development and application of
plant tissue culture-based technologies will require urgent
solutions to problems such as somaclonal variation, hyperhy-
dricity and shoot-tip necrosis. A better understanding and
elucidation of the underlying biochemical and molecular
mechanisms regulating cellular metabolic pathways may eventu-
ally provide long-lasting solutions to these and other physiolog-
ical challenges encountered in plant tissue culture applications.
Acknowledgements
The University of KwaZulu-Natal Research Office and the
National Research Foundation are acknowledged for the financial
support. Special thanks are due to Mr A.O. Aremu and the
anonymous reviewers for critically reading the manuscript. We
acknowledge that the research endeavours cited in this review are
indicative and do not represent the national output. Our sincere
1007M. Moyo et al. / South African Journal of Botany 77 (2011) 996–1011apologies to authors whose work is not cited to keep the
manuscript brief.References
Abrie, A.L., Van Staden, J., 2001. Micropropagation of the endangered Aloe
polyphylla. Plant Growth Regulation 33, 19–23.
Al-Bader, S., Frew, S.E., Essajee, I., Liu, V.Y., Daar, A.S., Singer, P.A., 2009.
Small but tenacious: SouthAfrica's health biotech sector. NatureBiotechnology
27, 427–445.
Amoo, S.O., Finnie, J.F., Van Staden, J., 2009a. In vitro propagation of Huernia
hystrix: an endangered medicinal and ornamental succulent. Plant Cell
Tissue and Organ Culture 96, 273–278.
Amoo, S.O., Finnie, J.F., Van Staden, J., 2009b. Effects of temperature,
photoperiod and culture vessel size on adventitious shoot production of in
vitro propagated Huernia hystrix. Plant Cell Tissue and Organ Culture 99,
233–238.
Amoo, S.O., Finnie, J.F., Van Staden, J., 2011. The role of meta-topolins in
alleviating micropropagation problems. Plant Growth Regulation 63,
197–206.
Andanda, P., 2009. Status of biotechnology policies in South Africa. Asian
Biotechnology and Development Review 11, 35–47.
Appleton, M.R., Van Staden, J., 1995. Micropropagation of some South African
Hypoxis species with medicinal and horticultural potential. Acta Horticul-
turae 420, 75–77.
Ascough, G.D., Van Staden, J., 2010. Micropropagation of Albuca bracteata
and A. nelsonii — indigenous ornamentals with medicinal value. South
African Journal of Botany 76, 579–584.
Ascough, G.D., Bakos, F., Balazs, E., Barnabás, B., Van Staden, J., 2006.
Screening South African wheat germplasm for androgenic competence.
South African Journal of Botany 72, 40–45.
Ascough, G.D., Erwin, J., Van Staden, J., 2007. In vitro propagation of four
Watsonia species. Plant Cell Tissue and Organ Culture 88, 135–145.
Ascough, G.D., Erwin, J.E., Van Staden, J., 2008. In vitro storage organ
formation on ornamental geophytes. Horticultural Reviews 34, 417–444.
Ascough, G., Erwin, J.E., VanStaden, J., 2009.Micropropagation of Iridaceae— a
review. Plant Cell Tissue and Organ Culture 97, 1–19.
Ascough, G.D., Swart, P.A., Finnie, J.F., Van Staden, J., 2011. Micropropaga-
tion of Romulea minutiflora, Sisyrinchium laxum and Tritonia gladiolaris-
Iridaceae with ornamental potential. South African Journal of Botany 77,
216–221.
Ault, J.R., 1995a. In vitro propagation of Eucomis autumnalis, E. comosa and E.
zambesiaca by twin-scaling. Hortscience 30, 1441–1442.
Ault, J.R., 1995b. In vitro rooting and greenhouse acclimatization of Lachenalia
shoots. Hortscience 30, 1304–1305.
Ault, J.R., 1996. In vitro rooting and greenhouse acclimatization of Veltheimia
bracteata and V. capensis shoots. Hortscience 30, 1229–1230.
Bailey, R.A., Bechet, G.R., 1989. A comparison of seedcane derived from tissue
culture with conventional seedcane. Proceedings of the South African Sugar
Technologists' Association 63, 125–129.
Bairu, M.W., Fennell, C.W., Van Staden, J., 2006. The effect of plant growth
regulators on somaclonal variation in Cavendish banana (Musa AAA cv.
‘Zelig’). Scientia Horticulturae 108, 347–351.
Bairu, M.W., Stirk, W.A., Doležal, K., Van Staden, J., 2007. Optimising the
micropropagation protocol for the endangered Aloe polyphylla: can meta-
topolin and its derivatives serve as replacement for benzyladenine and
zeatin? Plant Cell Tissue and Organ Culture 90, 15–23.
Bairu, M.W., Stirk, W.A., Doležal, K., Van Staden, J., 2008. The role of topolins
in micropropagation and somaclonal variation of banana cultivars
‘Williams’ and ‘Grand Naine’ (Musa spp. AAA). Plant Cell Tissue and
Organ Culture 95, 373–379.
Bairu, M.W., Stirk, W.A., Van Staden, J., 2009. Factors contributing to in vitro
shoot-tip necrosis and their physiological interactions. Plant Cell Tissue and
Organ Culture 98, 239–248.
Bairu, M.W., Amoo, S.O., Van Staden, J., 2011a. Comparative phytochemical
analysis of wild and in vitro-derived greenhouse-grown tubers. vitro shootsand callus-like basal tissues of Harpagophytum procumbens: South African
Journal of Botany, 77, pp. 479–484.
Bairu, M.W., Aremu, A.O., Van Staden, J., 2011b. Somaclonal variation in
plants: causes and detection methods. Plant Growth Regulation 63,
147–173.
Ben-Jaacov, J., Ackerman, A., Tal, E., Jacobs, G., 1991. Vegetative propagation
of Alberta magna by tissue culture and grafting. Hortscience 26, 74.
Berjak, P., Bartels, P., Benson, E.E., Harding, K., Mycock, D.J., Pammenter, N.W.,
Wesley-Smith, J., 2011. Cryopreservation of South African Plant Genetic
Diversity. In Vitro Cellular Developmental Biology-Plant 47, 65–81.
Bester, C., Bloemerus, L.M., Kleynhans, R., 2009. Development of new
floriculture crops in South Africa. Acta Horticulturae 813, 67–71.
Bornman, C.H., 2002. Somatic seed in conifer biotechnology — a viable
alternative to natural seed? South African Journal of Botany 68, 119–126.
Bornman, C.H., Dickens, O.S.P., Van der Merwe, C.F., Coetzee, J., Botha, A.-M.,
2003. Somatic embryos of Picea abies behave like isolated zygotic embryos
in vitro but with greatly reduced physiological vigour. SouthAfrican Journal of
Botany 69, 176–185.
Bornman, C.H., Grace, O.M., Van Staden, J., 2004. Sustainable biotechnology
for sub-Saharan Africa: can it be implemented and maintained? South
African Journal of Botany 70, 1–11.
Botha, A.-M., Venter, E., Van der Vyver, C., Kunert, K.J., 2004. Development
and application of molecular DNA markers in Africa: a South African view.
South African Journal of Botany 70, 152–166.
Brink, J.A., Woodward, B.R., DaSilva, E.J., 1998. Plant biotechnology: a tool
for development in Africa. Electronic Journal of Biotechnology 1, 142–151.
Canter, P.H., Thomas, H., Ernst, E., 2005. Bringing medicinal plants into
cultivation: opportunities and challenges for biotechnology. Trends in
Biotechnology 23, 180–185.
Cheesman, L., Finnie, J.F., Van Staden, J., 2010. Eucomis zambesiaca baker:
factors affecting in vitro bulblet induction. South African Journal of Botany 76,
543–549.
Chikwamba, R., Cunnick, J., Hathaway, D., McMurray, J., Maso, H., Wang, K.,
2002. A functional antigen in a practical crop: LT-B producing maize
protects mice against Escherichia coli heat labile entrotoxin (LT) and
cholera toxin (CT). Transgenic Research 11, 479–493.
Chukwujekwu, J.C., Van Staden, J., 2003. Tissue culture enhances the
propagation potential of some Tillandsioideae. South African Journal of
Botany 69, 214–216.
Chukwujekwu, J.C., Fennell, C.W., Van Staden, J., 2002. Optimization of the
tissue culture protocol for the endangered Aloe polyphylla. South African
Journal of Botany 68, 424–429.
Cloete, T.E., Nel, L.H., Theron, J., 2006. Biotechnology in South Africa. Trends
in Biotechnology 24, 557–562.
Colling, J., Groenewald, J.-H., Makunga, N.P., 2010a. Genetic alterations for
increased coumarin production lead to metabolic changes in the medicinally
important Pelargonium sidoides DC (Geraniaceae). Metabolic Engineering
12, 561–572.
Colling, J., Stander, M.A., Makunga, N.P., 2010b. Nitrogen supply and abiotic stress
influence canavanine synthesis and the productivity of in vitro regenerated
Sutherlandia frutescens microshoots. Journal of Plant Physiology 167,
1521–1524.
Cook, E.L., Cunningham, A., Van Staden, J., 1988. The tissue culture of an
exploited Zulu medicinal plant, Bowiea volubilis. South African Journal of
Botany 54, 509–510.
Crouch, I.J., Van Staden, J., 1988. In vitro propagation of Drosera natalensis.
South African Journal of Botany 54, 94–95.
Crouch, N.R., Van Staden, J., 1994. In vitro propagation of a number of South
African Oxalis species. South African Journal of Botany 60, 134–135.
Crouch, N.R., Van Staden, L.F., Van Staden, J., Drewes, F.E., Drewes, S.E.,
Meyer, H.J., 1993. Accumulation of cyaniding-3-glucoside in callus and cell
cultures of Oxalis reclinata. Journal of Plant Physiology 142, 109–111.
Crouch, N.R., Brunkhorst, M., McCartan, S.A., 1999. Micropropagation of
Scilla nervosa (Hyacinthaceae), a southern African medicinal bulb. South
African Journal of Botany 65, 306–307.
De Villiers, S.M., Kamo, K., Thompson, J.A., Bornman, C.H., Berger, D.K.,
2000. Biolistic transformation of chincherinchee (Ornithogalum) and
regeneration of transgenic plants. Physiologia Plantarum 109, 450–455.
1008 M. Moyo et al. / South African Journal of Botany 77 (2011) 996–1011Dickens, C.W.S., Kelly, K.M., Manning, J.C., Van Staden, J., 1986. In vitro
propagation of Gladiolus flanaganii. South African Journal of Botany 52,
485–487.
Drewes, F.E., Van Staden, J., 1993. In vitro propagation of Galtonia species.
South African Journal of Botany 59, 457–458.
Drewes, F.E., Van Staden, J., 1994. In vitro propagation of Gethyllis linearis
L. Bak., a rare indigenous bulb. South African Journal of Botany 60,
295–296.
Drewes, F.E., Bayley, A.D., Van Staden, J., 1993. Tissue culture of Schizobasis
intricata, a medicinal plant. South African Journal of Botany 59, 105–106.
DST, 2001. Department of Science and Technology. Accessed on March 30,
2011 National Biotechnology Strategy for South Africa. http://www.pub.ac.
za/resources/docs/biotechstrategy_2002.pdf.
DST, 2009. Department of Science and Technology news. Accessed on March
30, 2011 http://www.dst.gov.za/minister-pandor-announces-tia-board-
members/.
Engelmann, F., 2011. Use of Biotechnologies for the Conservation of Plant
Biodiversity. In Vitro Cellular Developmental Biology-Plant 47, 5–16.
Fennell, C.W., Van Staden, J., 2004. Biotechnology of southern African bulbs.
South African Journal of Botany 70, 37–46.
Fennell, C.W., Crouch, N.R., Van Staden, J., 2001. Micropropagation of the river
lily, Crinum variabile (Amaryllidaceae). South African Journal of Botany 67,
74–77.
Fennell, C.W., Elgorashi, E.E., Van Staden, J., 2003. Alkaloid production in
Crinum moorei cultures. Journal of Natural Products 66, 1524–1526.
Ferreira, S.J., Kossmann, J., Lloyd, J.R., Groenewald, J.-H., 2008. The
reduction of starch accumulation in transgenic sugarcane cell suspension
culture lines. Biotechnology Journal 3, 1398–1406.
Finnie, J.F., Van Staden, J., 1989. In vitro propagation of Sandersonia and
Gloriosa. Plant Cell Tissue and Organ Culture 19, 151–158.
Finnie, J.F., Drewes, F.E., Van Staden, J., 1994. Bowiea volubilis Harv. ex
Hook. In vitro culture and the production of cardiac glycosides. In: Bajaj, Y.
P.S. (Ed.), Biotechnology in Agriculture and Forestry: Medicinal and
Aromatic Plants VII, Vol. 28. Springer-Verlag, Berlin, pp. 84–97.
Flores, H.E., Vivanco, J.M., Loyola-Vargas, V.M., 1999. ‘Radicle’ biochemistry:
the biology of root-specific metabolism. Trends in Plant Science 4, 220–226.
Goldblatt, P., 1978. An analysis of the flora of southern Africa: its
characterization, relationship and origins. Annals of the Missouri Botanical
Gardens 65, 369–436.
Guillon, S., Trémouillaux-Guiller, J., Pati, P.K., Rideau, M., Gantet, P., 2006.
Harnessing the potential of hairy roots: dawn of a new era. Trends in
Biotechnology 24, 403–409.
Hajari, E., Watt, M.P., Mycock, D.J., McAlister, B., 2006. Plant regeneration
from induced callus of improved Eucalyptus clones. South African Journal
of Botany 72, 195–201.
Hannweg, K., Watt, M.P., Berjak, P., 1996. A simple method for the
micropropagation of Bowiea volubilis from inflorescence explants.
Botanical Bulletin of Academia Sinica 37, 213–218.
Huang, L.-D., Van Staden, J., 2002. Salvia chamelaeagnea can be
micropropagated and its callus induced to produce rosmarinic acid. South
African Journal of Botany 68, 177–180.
Hussey, G., 1976. Plantlet regeneration from callus and parent tissue in
Ornithogalum thyrsoides. Journal of Experimental Botany 27, 375–382.
International Atomic Energy Agency, 2004. Low cost options for tissue culture
technology in developing countries. Proceedings of a Technical Meeting
organized by the Joint FAO/IAEA Division of Nuclear Techniques in Food
and Agriculture, held in Vienna. 26–30 August 2002.
Jäger, A.K., McAlister, M.G., Van Staden, J., 1998. In vitro culture ofGladiolus
carneus. South African Journal of Botany 64, 146–147.
Jäger, K., Bartók, T., Ördög, V., Barnabás, B., 2010. Improvement of maize
(Zea mays L.) anther culture responses by algae-derived natural substances.
South African Journal of Botany 76, 511–516.
Jain,N., Light,M.E.,VanStaden, J., 2008.Antibacterial activity of hairy-root cultures
of Maytenus senegalensis. South African Journal of Botany 74, 163–166.
Jain, N., Bairu, M.W., Stirk, W.A., Van Staden, J., 2009. The effect of medium,
carbon source and explant on regeneration and control of shoot-tip necrosis
in Harpagophytum procumbens. South African Journal of Botany 75,
117–121.James, J.T., Meyer, R., Dubery, I.A., 2008. Characterization of two phenotypes
of Centella asiatica in Southern Africa through the composition of four
triterpenoids in callus, cell suspensions and leaves. Plant Cell Tissue and
Organ Culture 94, 91–99.
Jones, N.B., Van Staden, J., 1993. Somatic embryogenesis in Pinus patula.
Journal of Plant Physiology 142, 366–372.
Jones, N.B., Van Staden, J., 1994. Micropropagation and establishment of
Eucalyptus grandis hybrids. South African Journal of Botany 60, 122–126.
Jones, N.B., Van Staden, J., 1995. Plantlet production from somatic embryos of
Pinus patula. Journal of Plant Physiology 145, 519–525.
Jones, N.B., Mitchell, J., Bayley, A.D., Van Staden, J., 1992. In vitro
propagation of Thuranthos basuticum. South African Journal of Botany 58,
403–404.
Kim, K.W., De Hertogh, A.A., 1997. Tissue culture of ornamental flowering
bulbs (geophytes). Horticultural Reviews 18, 87–169.
Koetle, M.J., Finnie, J.F., Van Staden, J., 2010. In vitro regeneration inDierama
erectum Hilliard. Plant Cell Tissue and Organ Culture 103, 23–31.
Kowalski, B., Van Staden, J., 2001. Micropropagation of Podocarpus henkelii
and P. elongatus. South African Journal of Botany 67, 362–366.
Le Roux, J.J., Van Staden, J., 1991. Micropropagation and tissue culture of
Eucalyptus — a review. Tree Physiology 9, 435–477.
Louw, E., 1989. In vitro propagation of Lapeirousia silenoides. South African
Journal of Botany 55, 369–371.
Madubanya, L.A., Makunga, N.P., Fennell, C.W., 2006.Dierama luteoalbidum:
liquid culture provides an efficient system for the ex situ conservation of an
endangered and horticulturally valuable plant. South African Journal of
Botany 72, 584–588.
Makunga, N.P., Van Staden, J., 2008. An efficient system for the production of
clonal plantlets of the medicinally important aromatic plant: Salvia africana-
lutea L. Plant Cell Tissue and Organ Culture 92, 63–72.
Makunga, N.P., Van Staden, J., Cress, W.A., 1997. The effect of light and 2,4-D
on anthocyanin production in Oxalis reclinata callus. Plant Growth
Regulation 23, 153–158.
Makunga, N.P., Jäger, A.K., Van Staden, J., 2003. Micropropagation of Thapsia
garganica — a medicinal plant. Plant Cell Reports 21, 967–973.
Makunga, N.P., Jäger, A.K., Van Staden, J., 2005. An improved system for the in
vitro regeneration of Thapsia garganica via direct organogenesis— influence
of auxins and cytokinins. Plant Cell Tissue and Organ Culture 82, 271–280.
Makunga, N.P., Jäger, A.K., Van Staden, J., 2006. Improved in vitro rooting and
hyperhydricity in regenerating tissues of Thapsia garganica L. Plant Cell
Tissue and Organ Culture 82, 271–280.
Malabadi, R.B., Van Staden, J., 2003. Somatic embryos can be induced from the
vegetative shoot apex of mature Pinus patula trees. South African Journal of
Botany 69, 450–451.
Malabadi, R.B., Van Staden, J., 2004. Regeneration of Ornithogalum in vitro.
South African Journal of Botany 70, 618–621.
Malabadi, R.B., Van Staden, J., 2005a. Somatic embryogenesis from vegetative
shoot apices of mature trees of Pinus patula. Tree Physiology 25, 11–16.
Malabadi, R.B., Van Staden, J., 2005b. Storability and germination of sodium
alginate encapsulated somatic embryos derived from the vegetative shoot
apices of mature Pinus patula trees. Plant Cell Tissue and Organ Culture 82,
259–265.
Matkowski, A., 2008. Plant in vitro culture for the production of antioxidants—
a review. Biotechnology Advances 26, 548–560.
Matu, E.N., Lindsey, K.L., Van Staden, J., 2006. Micropropagation ofMaytenus
senegalensis (Lam.) Excell. South African Journal of Botany 72, 409–415.
McAlister, B.G., Van Staden, J., 1996. In vitro micropropagation of Kniphofia
pauciflora Bak. For conservation purposes. South African Journal of Botany
62, 219–221.
McAlister, B.G., Van Staden, J., 1998. In vitro culture of Eulophia species.
South African Journal of Botany 64, 264–266.
McAlister, B.G., Jäger, A.K., Van Staden, J., 1998a. Micropropagation of
Babiana spp. South African Journal of Botany 64, 88–90.
McAlister, B.G., Strydom, A., Van Staden, J., 1998b. In vitro propagation
of some Cyrtanthus species. South African Journal of Botany 64,
228–231.
McAlister, B., Finnie, J.F., Watt, M.P., Blakeway, F., 2005. Use of the
temporary immersion bioreactor system (RITA®) for production of
1009M. Moyo et al. / South African Journal of Botany 77 (2011) 996–1011commercial Eucalyptus clones in Mondi Forests (SA). Plant Cell Tissue and
Organ Culture 81, 347–358.
McCartan, S.A., Crouch, N.R., 1998. In vitro culture of Mondia whitei
(Periplocaceae), a threatened Zulu medicinal plant. South African Journal of
Botany 64, 313–314.
McCartan, S.A., Van Staden, J., 1996. In vitro propagation of the medicinal
plant, Eucomis poleevansii N.E. Brown. Journal of the South African
Society of Horticultural Science 5, 73–75.
McCartan, S.A., Van Staden, J., 1998. Micropropagation of the medicinal plant,
Scilla natalensis Planch. Plant Growth Regulation 25, 177–180.
McCartan, S.A., Van Staden, J., 1999. Micropropagation of members of the
Hyacinthaceae with medicinal and ornamental potential — a review. South
African Journal of Botany 65, 361–369.
McCartan, S.A., Van Staden, J., 2002. Micropropagation of Scilla krausii and
Scilla dracomontana. South African Journal of Botany 68, 223–225.
McCartan, S.A., Van Staden, J., 2003. Micropropagation of the endangered
Kniphofia leucocephala Baijnath. In Vitro Cellular Developmental Biology-
Plant 39, 496–499.
McCartan, S.A., Ramarosandratana, A.V., Van Staden, J., 2004. In vitro
germination and propagation of the ornamental restio, Ischyrolepis
subverticillata. South African Journal of Botany 70, 326–328.
Meyer, H.J., 1998. In vitro formation of adventitious buds on mature embryos of
Pinus elliotlii Engelm.×P. caribaeaMorelet hybrids. South African Journal
of Botany 64, 220–225.
Meyer, G.M., Banasiak, M., Ntoyi, T.T., Nicholson, T.L., Snyman, S.J., 2009.
Sugarcane plants from temporary immersion culture: acclimating for
commercial production. Acta Horticulturae 812, 323–328.
Mithila, J., Murch, S.J., KristinaRaj, S., Saxena, P.K., 2001. Recent advances in
Pelargonium in vitro regeneration systems. Plant Cell Tissue andOrganCulture
67, 1–9.
Mokotedi, M.E.O., Watt, M.P., Pammenter, N.W., Blakeway, F.C., 2003. In
vitro rooting and subsequent survival of two clones of a cold-tolerant
Eucalyptus grandis×E. nitens hybrid. Hortscience 35, 1163–1165.
Mollel, M.H.N., Goyvaerts, E.M.A., 2004. Preliminary examination of factors
affecting Agrobacterium tumefaciens-mediated transformation of marula,
Sclerocarya birrea subsp. caffra (Anacardiaceae). Plant Cell Tissue and
Organ Culture 79, 321–328.
Moyo, M., Finnie, J.F., Van Staden, J., 2009. In vitro morphogenesis of
organogenic nodules derived from Sclerocarya birrea subsp. caffra leaf
explants. Plant Cell Tissue and Organ Culture 98, 273–280.
Moyo, M., Finnie, J.F., Van Staden, J., 2011. Recalcitrant effects associated
with the development of basal callus-like tissue on caulogenesis
and rhizogenesis in Sclerocarya birrea. Plant Growth Regulation 63,
187–195.
Musarurwa, H.T., Van Staden, J., Makunga, N.P., 2010. In vitro seed
germination and cultivation of the aromatic medicinal Salvia stenophylla
(Burch. ex Benth.) provides an alternative source of α-bisabolol. Plant
Growth Regulation 61, 287–295.
Mycock, D.J., Wesley-Smith, J., Berjak, P., 1995. Cryopreservation of somatic
embryos of four species with and without cryoprotectant pre-treatment.
Annals of Botany 75, 331–336.
Mycock, D.J., Watt, M.P., Hannweg, K.F., Naicker, K., Makwanela, M., Berjak,
P., 1997. Somatic embryogenesis of the indigenous South African
Haworthia spp. (H. limifolia and H. koelmeniorum). South African Journal
of Botany 63, 345–350.
Ncube, B., Ngunge, V.N.P., Finnie, J.F., Van Staden, J., 2011. A comparative
study of the antimicrobial and phytochemical properties between outdoor
grown and micropropagated Tulbaghia violacea Harv. plants. Journal of
Ethnopharmacology 134, 775–780.
Nel, D.D., 1983. Rapid propagation of Lachenalia hybrids in vitro. South
African Journal of Botany 2, 245–246.
Ngugi, G.W., Jäger, A.K., Van Staden, J., 1998. In vitro propagation of Drimia
robusta Bak. South African Journal of Botany 64, 266–268.
Niederwieser, J.G., 2004. Role of biotechnology in the development and
production of Lachenalia and Ornithogalum cultivars in South Africa. South
African Journal of Botany 70, 47–51.
Niederwieser, J.G., Van Staden, J., 1990. The relationship between genotype,
tissue age and endogenous cytokinin levels on adventitious budformation on leaves of Lachenalia. Plant Cell Tissue and Organ Culture
22, 223–228.
Niederwieser, J.G., Van Staden, J., 1992. Interaction between benzyladenine,
naphthaleneacetic acid and tissue age on adventitious bud formation on leaf
sections of Lachenalia hybrids. South African Journal of Botany 58,
13–16.
Niederwieser, J.G., Vcelar, B.M., 1990. Regeneration of Lachenalia species
from leaf explants. Hortscience 25, 684–687.
Niederwieser, J.G., Van Staden, J., Upfold, S.J., Drewes, F.E., 1992.
Metabolism of 6-benzyladenine by leaf explants of Lachenalia during
adventitious bud formation. South African Journal of Botany 58, 236–238.
Nigro, S.A., Makunga, N.P., Grace, O.M., 2004a. Medicinal plants at the
ethnobotany-biotechnology interface in Africa. South African Journal of
Botany 70, 89–96.
Nigro, S.A., Makunga, N.P., Jones, N.B., Van Staden, J., 2004b. A biolistic
approach towards producing transgenic Pinus patula embryonal suspensor
masses. Plant Growth Regulation 44, 187–197.
Nigro, S.A., Makunga, N.P., Jones, N.B., Van Staden, J., 2008. An
Agrobacterium-mediated system for gene transfer in Pinus patula. South
African Journal of Botany 74, 144–148.
O'Kennedy, M.M., Burger, J.T., Berger, D.K., 2001. Transformation of elite
white maize using the particle inflow gun and detailed analysis of a low-
copy integration event. Plant Cell Reports 20, 721–730.
O'Kennedy, M.M., Burger, J.T., Botha, F.C., 2004a. Pearl millet transformation
system using the positive selectable marker gene phosphomannose
isomerase. Plant Cell Reports 22, 684–690.
O'Kennedy, M.M., Smith, G., Botha, F.C., 2004b. Improved regeneration
efficiency of a pearl millet (Pennisetum glaucum [L.] R.Br.) breeding line.
South African Journal of Botany 70, 502–508.
Ofir, Z.M., 1994. Biotechnology in the new South Africa. Biotechnology and
Development Monitor 20, 14–15.
Okole, B.N., Odhav, B., 2004. Commercialization of plants in Africa. South
African Journal of Botany 70, 109–115.
Oksman-Caldentey, K.-M., Inze', D., 2004. Plant cell factories in the post-
genomic era: new ways to produce designer secondary metabolites. Trends
in Plant Science 9, 433–440.
Page, Y.M., Van Staden, J., 1985. In vitro propagation of Dierama latifolium.
Hortscience 20, 1049–1050.
Page, Y.M., Van Staden, J., 1986. In vitro propagation of Hypoxis rooperi from
flower buds. South African Journal of Botany 52, 261–264.
Pérez-Francés, J.F., Ravelo, B.J., Rodríguez-Pérez, J.A., 2001a. In vitro
establishment and proliferation of axillary bud cultures of Leucadendron
discolor (Proteaceae). Acta Horticulturae 545, 179–185.
Pérez-Francés, J.F., Raya Ramallo, V., Rodríguez-Pérez, J.A., 2001b. Micro-
propagation of Leucospermun ‘Sunrise’ (Proteaceae). Acta Horticulturae 545,
161–170.
Pouris, A., 2008. Review of the funding environment for biotechnology in South
Africapdf Accessed on June 03, 2011 http://www.nacinnovation.biz/wp-content/
uploads/the-funding-environment-of-South-African-biotechnology.
Prakash, S., Van Staden, J., 2007. Micropropagation of Hoslundia opposita
Vahl — a valuable medicinal plant. South African Journal of Botany 73,
60–63.
Prakash, S., Van Staden, J., 2008. Micropropagation of Searsia dentata. In Vitro
Cellular and Developmental Biology-Plant 44, 338–341.
Rabe, T., Van Staden, J., 1999. In vitro propagation of three Haemanthus
species. South African Journal of Botany 65, 438–440.
Rai, M.K., Asthana, P., Singh, S.K., Jaiswal, V.S., Jaiswal, U., 2009. The
encapsulation technology in fruit plants — a review. Biotechnology
Advances 27, 671–679.
Ramachandra Rao, S.R., Ravishankar, G.A., 2002. Plant cell cultures: chemical
factories of secondary metabolites. Biotechnology Advances 20, 101–153.
Ramgareeb, S., Snyman, S.J., Van Antwerpen, T., Rutherford, R.S., 2010.
Elimination of virus and rapid propagation of disease-free sugarcane
(Saccharum spp. cultivar NCo376) using apical meristem culture. Plant Cell
Tissue and Organ Culture 100, 175–181.
Ran, Y., Simpson, S., 2005. In vitro propagation of the genus Clivia. Plant Cell
Tissue and Organ Culture 81, 239–242.
Rates, S.M.K., 2001. Plants as sources of drugs. Toxicon 39, 603–613.
1010 M. Moyo et al. / South African Journal of Botany 77 (2011) 996–1011Red list of South African plants. 2009. Accessed on 29March 2011. www.sanbi.
org/biodiversity.
Rice, L.J., Finnie, J.F., Van Staden, J., 2011. In vitro bulblet production of
Brunsvigia undulata from twin-scales. South African Journal of Botany 77,
305–312.
Rossin, C.B., Rey, M.E.C., 2011. Effect of explant source and auxins on somatic
embryogenesis of selected cassava (Manihot esculenta Crantz) cultivars.
South African Journal of Botany 77, 59–65.
Rugge, B.A., 1995. Micropropagation of Protea repens. Acta Horticulturae 387,
121–127.
Rybicki, E.P., 2010. Plant-made vaccines for humans and animals. Plant
Biotechnology Journal 8, 620–637.
SANBI, 2011. The South African National Biodiversity Institute (SANBI)
webpage. Accessed on March 28, 2011 http://www.sanbi.org/index.php?
option=com_content&view=article&id=1&Itemid=135.
Shaik, S., Dewir, Y.H., Singh, N., Nicholas, A., 2010. Micropropagation
and bioreactor studies of the medicinally important plant Lessertia
(Sutherlandia) frutescens L. South African Journal of Botany 76,
180–186.
Shaik, S., Singh, N., Nicholas, A., 2011. HPLC and GC analyses of in vitro-
grown leaves of the cancer bush Lessertia (Sutherlandia) frutescens L.
reveal higher yields of bioactive compounds. Plant Cell Tissue and Organ
Culture 105, 431–438.
Shanks, J.V., Morgan, J., 1999. Plant ‘hairy root’ culture. Current Opinion in
Biotechnology 10, 151–155.
Sherwin, H., 2006. The challenges of starting up a biotech company in South
Africa. Accessed on June 10, 2011 http://www.biosa.org.za/pdfs/
heathersherwin.pdf2006.
Shih, S.M.-H., Doran, P.M., 2009. Foreign protein production using plant cell
and organ cultures: advantages and limitations. Biotechnology Advances 27,
1036–1042.
Shushu, D.D., 2001. In vitro regeneration of the Kalahari devil's claw,
Harpagophytum procumbens, an important medicinal plant. South African
Journal of Botany 67, 378–380.
Slabbert, M.M., Niederwieser, J.G., 1999. In vitro bulblet formation of
Lachenalia. Plant Cell Reports 18, 620–624.
Slabbert, M.M., De Bruyn, M.H., Ferreira, D.I., Pretorius, J., 1993.
Regeneration of bulblets from twin-scales of Crinum macowanii in vitro.
Plant Cell Tissue and Organ Culture 33, 133–141.
Slabbert, M.M., De Bruyn, M.H., Ferreira, D.I., Pretorius, J., 1995. Adventitious
in vitro plantlet formation from immature floral stems of Crinum macowanii.
Plant Cell Tissue and Organ Culture 43, 51–57.
Snyman, S.J., Meyer, G.M., Carson, D., Botha, F.C., 1996. Establishment of
embryogenic callus and transient gene expression in selected sugarcane
varieties. South African Journal of Botany 62, 151–154.
Snyman, S.J., Watt, M.P., Huckett, B.I., Botha, F.C., 2000. Direct somatic
embryogenesis for rapid, cost effective production of transgenic sugarcane
(Saccharum spp. hybrids). Proceedings of the South African Sugar
Technologists' Association 74, 186–187.
Snyman, S.J., Huckett, B.I., Botha, F.C., Watt, M.P., 2001. A comparison of
direct and indirect somatic morphogenesis for the production of transgenic
sugarcane (Saccharum spp. hybrids). Acta Horticulturae 56, 105–108.
Snyman, S.J., Meyer, G.M., Richards, J.M., Haricharan, N., Ramgareeb, S.,
Huckett, B.I., 2006. Refining the application of direct embryogenesis in
sugarcane: effect of the developmental phase of leaf disc explants and the
timing of DNA transfer on transformation efficiency. Plant Cell Reports 35,
1016–1023.
Snyman, S.J., Van Antwerpen, T., Ramdeen, V., Meyer, G.M., Richards, J.M.,
Rutherford, R.S., 2007. Micropropagation by direct somatic embryogenesis:
is disease elimination also a possibility? Proceedings of the International
Society of Sugar Cane Technologists 26, 943–946.
Snyman, S.J., Baker, C., Huckett, B.I., McFarlane, S.A., Van Antwerpen, T.,
Berry, S., Omarjee, J., Rutherford, R.S., Watt, D.A., 2008a. South African
Sugarcane Research Institute: embracing biotechnology for crop improve-
ment research. Sugar Tech 10, 1–13.
Snyman, S.J., Meyer, G.M., Banasiak, M., Nicholson, T.L., Van Antwerpen, T.,
Naidoo, P., Erasmus, J.D., 2008b. Micropropagation of sugarcane viaNovaCane®: preliminary steps in commercial application. Proceedings of
the South African Sugar Technologists' Association 81, 513–516.
Snyman, S.J., Nkwanyana, P.D., Watt, M.P., 2011a. Alleviation of hyperhy-
dricity of sugarcane plantlets produced in RITA® vessels and genotypic and
phenotypic characterization of acclimated plants. South African Journal of
Botany 77, 685–692.
Snyman, S.J., Meyer, G.M., Koch, A.C., Banasiak, M., Watt, M.P., 2011b.
Applications of in vitro culture systems for commercial sugarcane
production and improvement. In Vitro Cellular and Developmental
Biology-Plant 47, 234–249.
Sparg, S.G., Jones, N.B., Van Staden, J., 2002. Artificial seed from Pinus patula
somatic embryos. South African Journal of Botany 68, 234–238.
Srivastava, P., Chaturvedi, R., 2008. In vitro androgenesis in tree species: an
update and prospect for further research. Biotechnology Advances 26,
482–491.
Taylor, J.L.S., Van Staden, J., 1997. In vitro propagation of Veltheimia
bracteata and V. bracteata “Lemon Flame”. South African Journal of
Botany 63, 159–161.
Taylor, J.L.S., Van Staden, J., 2001a. In vitro propagation of Eucomis L'Herit
species — plants with medicinal and horticultural potential. Plant Growth
Regulation 34, 317–329.
Taylor, J.L.S., Van Staden, J., 2001b. The effect of nitrogen and sucrose
concentrations on the growth of Eucomis autumnalis (Mill.) Chitt. plantlets
in vitro, and on subsequent anti-inflammatory activity in extracts prepared
from the plantlets. Plant Growth Regulation 34, 49–56.
Taylor, J.L.S., Van Staden, J., 2001c. Anti-inflammatory activity in extracts
prepared from callus cultures of Eucomis autumnalis (Mill.) Chitt. Plant
Growth Regulation 34, 331–337.
Taylor, N.J., Light, M.E., Van Staden, J., 2005. In vitro flowering of Kniphofia
leucocephala: influence of cytokinins. Plant Cell Tissue and Organ Culture
83, 327–333.
Tetyana, P., Van Staden, J., 2001. Micropropagation of Cussonia paniculata—
a medicinal plant with horticultural potentials. South African Journal of
Botany 67, 367–370.
UNEP, 1992. Convention on Biological Diversity, Article 2. United Nations
Environment Programme. Accessed on March 30, 2011 http://www.cbd.int.
Upfold, S.J., Van Staden, J., Edwards, T.J., 1992. In vitro propagation of
Rhodohypoxis baurii. Hortscience 27, 1230.
Van Rensburg, J.G.J., Vcelar, B.M., Landy, P.A., 1989. Micropropagation of
Ornithogalum maculatum. South African Journal of Botany 55, 137–139.
Van Staden, J., Choveaux, N.A., Gilliland, M.G., McDonald, D.J., Davey, J.E.,
1981. Tissue culture of South African Proteacea. 1. Callus and proteoid
rootlet formation on cotyledonary explants of Protea neriifolia. South Africa
Journal of Science 77, 493–495.
Van Staden, J., Elmer-English, C.W., Finnie, J.F., 1991. Physiological and
anatomical aspects related to in vitro shoot initiation in Bowiea volubilis.
South African Journal of Botany 57, 352–355.
Van Vuuren, P.J., 1995. New ornamental crops in South Africa. Acta
Horticulturae 397, 71–84.
IUCNRed List of Threatened Plants, 1997. In: Walters, K.S., Gillett, H.J. (Eds.),
Compiled by the World Conservation Monitoring Centre. IUCN — The
World Conservation Union, Gland, Switzerland and Cambridge, UK, p. 862.
Watt, M.P., Blakeway, F., Cresswell, C.F., Herman, B., 1991. Somatic embryogen-
esis in Eucalyptus grandis. South African Forestry Journal 157, 59–65.
Watt, M.P., Mycock, D.J., Blakeway, F.C., Berjak, P., 2000a. Application of in
vitro methods to Eucalyptus germplasm conservation. Southern African
Forestry Journal 187, 3–10.
Watt, M.P., Thokoane, N.L., Mycock, D., Blakeway, F., 2000b. In vitro storage
of Eucalyptus grandis germplasm under minimal growth conditions. Plant
Cell Tissue and Organ Culture 61, 161–164.
Watt, M.P., Berjak, P., Makhathini, A., Blakeway, F., 2003a. In vitro field
collection techniques for Eucalyptus micropropagation. Plant Cell Tissue
and Organ Culture 75, 233–240.
Watt, M.P., Blakeway, F.C., Mokotedi, M.E.O., Jain, S.M., 2003b. Micro-
propagation of Eucalyptus. In: Jain, S.M., Ishii, K. (Eds.), Micropropagation
of Woody Trees and Fruits. Kluwer Academic Publishers, Dordrecht, pp.
217–244.
1011M. Moyo et al. / South African Journal of Botany 77 (2011) 996–1011Watt, M.P., Banasiak, M., Reddy, D., Albertse, E.H., Snyman, S.J., 2009. In
vitro minimal growth storage of Saccharum spp. Hybrid (genotype
88H0019) at two stages of direct somatic embryogenic regeneration. Plant
Cell Tissue and Organ Culture 96, 263–271.
World University Ranking, Q.S., 2010. Accessed on March 29, 2011 http://
www.topuniversities.com/university-rankings/world-university-rankings/
2010.
Wu, H.C., Du Toit, E.S., 2004. Reducing oxidative browning during in vitro
establishment of Protea cynaroides. Scientia Horticulturae 100, 355–358.
Wu, H.C., Du Toit, E.S., Reinhardt, C.F., 2007. A protocol for direct somatic
embryogenesis of Protea cynaroides L. using zygotic embryos and
cotyledon tissues. Plant Cell Tissue and Organ Culture 89, 217–224.Xu, J., Ge, X., Dolan, M.C., 2011. Towards high-yield production of
pharmaceutical proteins with plant cell suspension cultures. Biotechnology
Advances 29, 278–299.
Ziaratnia, S.M., Ohyama, K., Hussein, A.A.-F., Muranaka, T., Lall, N., Kunert,
K.J., Meyer, J.J.M., 2009. Isolation and identification of a novel
chlorophenol from a cell suspension culture of Helichrysum aureonitens.
Chemical and Pharmaceutical Bulletin 57, 1282–2183.
Zschocke, S., Van Staden, J., 2000. In vitro propagation of Tulbaghia simmleri.
South African Journal Botany 66, 86–89.Edited by AM Viljoen
